<h2>盈利激增和稳定的股息使上美股份备受关注</h2>
<p>上美股份（香港证券交易所代码：2145）在报告 2025 财年销售额和净收入增长的同时，提出每股人民币 0.75 的最终股息，与 2024 年持平，因此引起了新的关注。</p>
<p>请查看我们对上美股份的最新分析。</p>
<p>尽管有盈利和股息的消息，但最近 30 天股价回报率为 14.81%，年初至今股价回报率为 26.22%，显示出动能减弱。然而，三年总股东回报率超过 100% 突显了长期持有者的不同体验。</p>
<p>如果您将上美股份与其他消费领域的公司进行比较，查看更广泛公司（包括 95 家顶级创始人领导的公司）的质量和增长情况将会很有帮助。</p>
<p>因此，在盈利和股息保持稳定的同时，股价最近出现回调，上美股份是否现在的交易价格低于其基本面所暗示的水平，还是市场已经在定价未来的增长？</p>
<h2>16.1 倍的市盈率：是否合理？</h2>
<p>上美股份的市盈率为 16.1 倍，略低于其估计的公允市盈率 19.2 倍和同行平均市盈率 16.2 倍。</p>
<p>市盈率将每股 51.2 港元的股价与公司的每股收益进行比较，因此反映了投资者目前愿意为每单位利润支付的价格。</p>
<p>对于上美股份，多个因素支撑了这一数字。过去一年，盈利增长 41.1%，五年年均增长 39.9%，且盈利质量高，股本回报率为 40.2%。预计年均盈利增长 17.5% 和年均收入增长 17.1%，均高于香港市场的整体水平，表明投资者正在为一个预计利润将持续扩张的企业付出代价，即使增长不被视为非常高。</p>
<p>与亚洲个人护理产品行业的 21.3 倍市盈率相比，上美股份的 16.1 倍在相对上显得更便宜。此外，19.2 倍的公允市盈率估计表明，如果当前的盈利质量和增长趋势持续，市场可能会朝这个水平移动。</p>
<p>探索上美股份的 SWS 公允比率</p>
<p><strong>结果：16.1 倍的市盈率（被低估）</strong></p>
<p>然而，最近股价下跌，加上对中国大陆收入集中度的高度依赖，可能会迅速挑战当前估值故事的信心。</p>
<p>了解上美股份叙述中的关键风险。</p>
<h2>SWS DCF 模型的另一种观点</h2>
<p>虽然 16.1 倍的市盈率表明上美股份在同行和公允比率中看起来便宜，但 SWS DCF 模型则指向相反的方向。从现金流的角度来看，51.2 港元的股价高于估计值 42.27 港元，这意味着股票被视为高估。</p>
<p>这种基于盈利和基于现金流的方法之间的分歧对您作为投资者可能很重要。增长和质量可能证明支付高价是合理的，但这也引发了一个问题：如果情绪从这里降温，您愿意承担多少估值风险。</p>
<p>了解 SWS DCF 模型如何得出其公允价值。</p>
<p>Simply Wall St 每天对全球每只股票进行折现现金流（DCF）分析（例如查看上美股份）。我们展示了完整的计算过程。您可以在您的观察列表或投资组合中跟踪结果，并在变化时收到提醒，或者使用我们的股票筛选器发现 235 只高质量被低估的股票。如果您保存筛选器，我们甚至会在新公司匹配时提醒您——这样您就不会错过潜在机会。</p>
<h2>下一步</h2>
<p>在价值和情绪信号混合的情况下，自己深入研究是明智的，权衡潜在收益和风险之间的权衡，并查看 3 个关键收益和 1 个重要警示信号。</p>
<h2>寻找更多投资想法？</h2>
<p>如果您只停留在一家公司，您可能会错过其他更适合您风格的机会。尝试通过几个聚焦的筛选器扩大您的视野。</p>
<ul>
<li>通过扫描具有更强的资产负债表和基本面的企业，目标是持续的现金生成，使用稳健的资产负债表和基本面股票筛选器（384 个结果）。</li>
<li>通过检查将质量指标与价格结合的公司，寻找潜在价值，这些公司在 235 只高质量被低估的股票中筛选为有吸引力。</li>
<li>通过审查 226 只具有强大财务的精英便士股票，发现由稳健财务支持的早期机会，以便在市场更关注之前。</li>
</ul>
<p><em>本文由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们旨在为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>

上美股份

<p>上海上美股份（SEHK:2145）报告了 2025 年强劲的收益，净利润增长 41.1%，并提议每股派发稳定的最终股息人民币 0.75 元。尽管近期股价下跌，该公司的市盈率为 16.1 倍，低于其合理市盈率 19.2 倍和行业平均市盈率 21.3 倍，暗示其可能被低估。然而，现金流折现分析显示，股价在 51.2 港元时可能被高估，估计价值为 42.27 港元。建议投资者权衡增长潜力与估值风险之间的利弊</p>

<h2>Earnings jump and steady dividend put Shanghai Chicmax Cosmetic in focus</h2>
<div class="lb-trans"><h2>盈利激增和稳定的股息使上美股份备受关注</h2>
</div><p>Shanghai Chicmax Cosmetic (SEHK:2145) has drawn fresh attention after reporting higher full year 2025 sales and net income, alongside a proposed final dividend of RMB 0.75 per share, unchanged from 2024.</p>
<div class="lb-trans"><p>上美股份（香港证券交易所代码：2145）在报告 2025 财年销售额和净收入增长的同时，提出每股人民币 0.75 的最终股息，与 2024 年持平，因此引起了新的关注。</p>
</div><p>See our latest analysis for Shanghai Chicmax Cosmetic.</p>
<div class="lb-trans"><p>请查看我们对上美股份的最新分析。</p>
</div><p>Despite the earnings and dividend news, the recent 30 day share price return of 14.81% and year to date share price return of 26.22% point to fading momentum. However, the 3 year total shareholder return of over 100% highlights how longer term holders have had a very different experience.</p>
<div class="lb-trans"><p>尽管有盈利和股息的消息，但最近 30 天股价回报率为 14.81%，年初至今股价回报率为 26.22%，显示出动能减弱。然而，三年总股东回报率超过 100% 突显了长期持有者的不同体验。</p>
</div><p>If you are comparing Shanghai Chicmax Cosmetic with other names in the consumer space, it can be helpful to see how quality and growth look across a broader set of companies, including those in the 95 top founder-led companies</p>
<div class="lb-trans"><p>如果您将上美股份与其他消费领域的公司进行比较，查看更广泛公司（包括 95 家顶级创始人领导的公司）的质量和增长情况将会很有帮助。</p>
</div><p>So, with earnings and dividends holding up while the share price has seen a recent pullback, is Shanghai Chicmax Cosmetic now trading below what its fundamentals suggest, or is the market already pricing in future growth?</p>
<div class="lb-trans"><p>因此，在盈利和股息保持稳定的同时，股价最近出现回调，上美股份是否现在的交易价格低于其基本面所暗示的水平，还是市场已经在定价未来的增长？</p>
</div><h2>Price-to-earnings of 16.1x: Is it justified?</h2>
<div class="lb-trans"><h2>16.1 倍的市盈率：是否合理？</h2>
</div><p>Shanghai Chicmax Cosmetic trades on a P/E of 16.1x, which sits slightly below both its estimated fair P/E of 19.2x and the peer average of 16.2x.</p>
<div class="lb-trans"><p>上美股份的市盈率为 16.1 倍，略低于其估计的公允市盈率 19.2 倍和同行平均市盈率 16.2 倍。</p>
</div><p>The P/E ratio compares the HK$51.2 share price with the company’s earnings per share. It therefore reflects what investors are currently willing to pay for each unit of profit.</p>
<div class="lb-trans"><p>市盈率将每股 51.2 港元的股价与公司的每股收益进行比较，因此反映了投资者目前愿意为每单位利润支付的价格。</p>
</div><p>For Shanghai Chicmax Cosmetic, several factors sit behind that number. Earnings grew 41.1% over the past year and have grown 39.9% per year over five years, with high quality earnings and a 40.2% return on equity. Forecast earnings growth of 17.5% per year and revenue growth of 17.1% per year, both ahead of the wider Hong Kong market, indicate that investors are paying for a business where profits are expected to keep expanding, even if growth is not classed as very high.</p>
<div class="lb-trans"><p>对于上美股份，多个因素支撑了这一数字。过去一年，盈利增长 41.1%，五年年均增长 39.9%，且盈利质量高，股本回报率为 40.2%。预计年均盈利增长 17.5% 和年均收入增长 17.1%，均高于香港市场的整体水平，表明投资者正在为一个预计利润将持续扩张的企业付出代价，即使增长不被视为非常高。</p>
</div><p>Compared with the Asian Personal Products industry P/E of 21.3x, Shanghai Chicmax Cosmetic’s 16.1x looks cheaper in relative terms. In addition, the fair P/E estimate of 19.2x points to a level the market could potentially move toward if current earnings quality and growth trends persist.</p>
<div class="lb-trans"><p>与亚洲个人护理产品行业的 21.3 倍市盈率相比，上美股份的 16.1 倍在相对上显得更便宜。此外，19.2 倍的公允市盈率估计表明，如果当前的盈利质量和增长趋势持续，市场可能会朝这个水平移动。</p>
</div><p>Explore the SWS fair ratio for Shanghai Chicmax Cosmetic</p>
<div class="lb-trans"><p>探索上美股份的 SWS 公允比率</p>
</div><p><strong>Result: Price-to-earnings of 16.1x (UNDERVALUED)</strong></p>
<div class="lb-trans"><p><strong>结果：16.1 倍的市盈率（被低估）</strong></p>
</div><p>However, recent share price declines, along with heavy exposure to Mainland China revenue concentration, could quickly challenge confidence in the current valuation story.</p>
<div class="lb-trans"><p>然而，最近股价下跌，加上对中国大陆收入集中度的高度依赖，可能会迅速挑战当前估值故事的信心。</p>
</div><p>Find out about the key risks to this Shanghai Chicmax Cosmetic narrative.</p>
<div class="lb-trans"><p>了解上美股份叙述中的关键风险。</p>
</div><h2>Another view from the SWS DCF model</h2>
<div class="lb-trans"><h2>SWS DCF 模型的另一种观点</h2>
</div><p>While the 16.1x P/E suggests Shanghai Chicmax Cosmetic looks inexpensive against peers and its fair ratio, the SWS DCF model points the other way. On this cash flow view, the HK$51.2 share price sits above an estimated value of HK$42.27, which implies the shares screen as overvalued instead.</p>
<div class="lb-trans"><p>虽然 16.1 倍的市盈率表明上美股份在同行和公允比率中看起来便宜，但 SWS DCF 模型则指向相反的方向。从现金流的角度来看，51.2 港元的股价高于估计值 42.27 港元，这意味着股票被视为高估。</p>
</div><p>This kind of split verdict between earnings based and cash flow based approaches can matter for you as an investor. Growth and quality may justify paying up, but it also raises the question of how much valuation risk you are comfortable carrying if sentiment cools from here.</p>
<div class="lb-trans"><p>这种基于盈利和基于现金流的方法之间的分歧对您作为投资者可能很重要。增长和质量可能证明支付高价是合理的，但这也引发了一个问题：如果情绪从这里降温，您愿意承担多少估值风险。</p>
</div><p>Look into how the SWS DCF model arrives at its fair value.</p>
<div class="lb-trans"><p>了解 SWS DCF 模型如何得出其公允价值。</p>
</div><p>Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Shanghai Chicmax Cosmetic for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 235 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.</p>
<div class="lb-trans"><p>Simply Wall St 每天对全球每只股票进行折现现金流（DCF）分析（例如查看上美股份）。我们展示了完整的计算过程。您可以在您的观察列表或投资组合中跟踪结果，并在变化时收到提醒，或者使用我们的股票筛选器发现 235 只高质量被低估的股票。如果您保存筛选器，我们甚至会在新公司匹配时提醒您——这样您就不会错过潜在机会。</p>
</div><h2>Next Steps</h2>
<div class="lb-trans"><h2>下一步</h2>
</div><p>With mixed signals on value and sentiment, it makes sense to look under the hood yourself, weigh the trade off between upside and risk, and see the 3 key rewards and 1 important warning sign</p>
<div class="lb-trans"><p>在价值和情绪信号混合的情况下，自己深入研究是明智的，权衡潜在收益和风险之间的权衡，并查看 3 个关键收益和 1 个重要警示信号。</p>
</div><h2>Looking for more investment ideas?</h2>
<div class="lb-trans"><h2>寻找更多投资想法？</h2>
</div><p>If you only stop at one company, you risk missing other opportunities that might suit your style even better. Try widening your net with a few focused screens.</p>
<div class="lb-trans"><p>如果您只停留在一家公司，您可能会错过其他更适合您风格的机会。尝试通过几个聚焦的筛选器扩大您的视野。</p>
</div><ul>
<li>Target consistent cash generation by scanning for businesses with stronger balance sheets and fundamentals using the solid balance sheet and fundamentals stocks screener (384 results).</li>
<li>Hunt for potential value by checking companies that combine quality metrics with pricing that screens as attractive in the 235 high quality undervalued stocks.</li>
<li>Spot early stage opportunities backed by solid financials by reviewing the 226 elite penny stocks with strong financials before the market pays closer attention.</li>
</ul>
<div class="lb-trans"><ul>
<li>通过扫描具有更强的资产负债表和基本面的企业，目标是持续的现金生成，使用稳健的资产负债表和基本面股票筛选器（384 个结果）。</li>
<li>通过检查将质量指标与价格结合的公司，寻找潜在价值，这些公司在 235 只高质量被低估的股票中筛选为有吸引力。</li>
<li>通过审查 226 只具有强大财务的精英便士股票，发现由稳健财务支持的早期机会，以便在市场更关注之前。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>本文由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们旨在为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div>

上海上美化妆品（SEHK:2145）在 2025 年实现强劲收益和稳定股息后的估值